CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License ...
Australia’s medicines regulator has confirmed it is evaluating a low dose for children as young as six-months-old.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results